Septerna, Inc. Common Stock (SEPN NASDAQ) stock market data APIs
$26.0968
0.89(3.4%)
as of December 8, 2025
Try our APIs with
free plan!
Septerna, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. The company also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders, including obesity and type 2 diabetes. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
Prev. Close
26.0968
Open
26.9859
High
27.5684
Low
25.9928
52 wk Range
4.17-29.735
Market Cap
1 162 M
Shares Outstanding
44 774 K
Revenue
22 045 K
EPS
0.18
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Septerna, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Septerna, Inc. Common Stock data using free add-ons & libraries
Get Septerna, Inc. Common Stock Fundamental Data
Septerna, Inc. Common Stock Fundamental data includes:
- Net Revenue: 22 045 K
- EBITDA: -87 901 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-10
- EPS/Forecast: -0.65
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Septerna, Inc. Common Stock News
New
Septerna to Participate in 8th Annual Evercore Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug di...
Septerna, Inc. GAAP EPS of $0.18, revenue of $21.5M
* Septerna, Inc. press release [https://seekingalpha.com/pr/20300040-septerna-highlights-company-progress-and-reports-third-quarter-2025-financial-results] (SEPN [https://seekingalpha.com/symbol/SEP...
Strength Seen in Moderna (MRNA): Can Its 13.9% Jump Turn into More Strength?
Moderna MRNA shares rallied 13.9% in the last trading session to close at $28.14. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session....
Strength Seen in Septerna, Inc. (SEPN): Can Its 7.0% Jump Turn into More Strength?
Septerna, Inc. (SEPN) shares soared 7% in the last trading session to close at $22.49. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares t...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
